Antibody-based point-of-care device for the diagnosis of sickle cell disease
Ended Project Grant Awarded Last action
- Award ID
- R43HL123472
- Recipient
-
Rockland Immunochemicals Inc. UEI NFKNUGEMMY18
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $489,072
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Pottstown, PA 19464, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $40,000 | |
| Amendment | $224,635 | |
| Original award | $224,437 |
Quick answers
Who received award R43HL123472?
R43HL123472 was awarded to Rockland Immunochemicals Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2014.
How much is award R43HL123472 worth?
$489,072 has been obligated on R43HL123472.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award